Literature DB >> 28025747

Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.

Burton I Korelitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28025747     DOI： 10.1007/s10620-016-4419-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

1.  Mucosal healing as an index of colitis activity: back to histological healing for future indices.

Authors:  Burton I Korelitz
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

2.  Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.

Authors:  Caroline Prieux-Klotz; Stéphane Nahon; Aurelien Amiot; Leila Sinayoko; Carole Galéano-Cassaz; Stanislas Chaussade; Romain Coriat; Pierre Lahmek; Vered Abitbol
Journal:  Dig Dis Sci       Date:  2016-11-16       Impact factor: 3.199

3.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

4.  6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.

Authors:  Burton I Korelitz; Daniel H Present
Journal:  J Crohns Colitis       Date:  2014-01-22       Impact factor: 9.071

5.  Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.

Authors:  Burton I Korelitz
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

6.  Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease.

Authors:  Shomron Ben-Horin; Matti Waterman; Uri Kopylov; Miri Yavzori; Orit Picard; Ella Fudim; Halim Awadie; Batia Weiss; Yehuda Chowers
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-24       Impact factor: 11.382

7.  The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.

Authors:  D J Adler; B I Korelitz
Journal:  Am J Gastroenterol       Date:  1990-06       Impact factor: 10.864

8.  Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.

Authors:  D H Present; B I Korelitz; N Wisch; J L Glass; D B Sachar; B S Pasternack
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

9.  Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.

Authors:  Robert V Bryant; Daniel C Burger; Joseph Delo; Alissa J Walsh; Sally Thomas; Axel von Herbay; Otto C Buchel; Lydia White; Oliver Brain; Satish Keshav; Bryan F Warren; Simon P L Travis
Journal:  Gut       Date:  2015-05-18       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.